Intuitive Surgical, Inc. $ISRG Shares Purchased by Mariner LLC

Mariner LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.7% in the 4th quarter, HoldingsChannel reports. The firm owned 132,129 shares of the medical equipment provider’s stock after buying an additional 31,784 shares during the quarter. Mariner LLC’s holdings in Intuitive Surgical were worth $74,858,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of the stock. MayTech Global Investments LLC raised its position in shares of Intuitive Surgical by 2.2% during the 4th quarter. MayTech Global Investments LLC now owns 70,955 shares of the medical equipment provider’s stock worth $40,189,000 after purchasing an additional 1,548 shares during the last quarter. Motiv8 Investments LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $34,000. Nicolet Advisory Services LLC raised its position in shares of Intuitive Surgical by 3.3% during the 4th quarter. Nicolet Advisory Services LLC now owns 1,233 shares of the medical equipment provider’s stock worth $706,000 after purchasing an additional 39 shares during the last quarter. Focus Partners Wealth raised its position in shares of Intuitive Surgical by 41.9% during the 4th quarter. Focus Partners Wealth now owns 122,735 shares of the medical equipment provider’s stock worth $68,909,000 after purchasing an additional 36,232 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC raised its position in shares of Intuitive Surgical by 244.0% during the 4th quarter. Financial Network Wealth Advisors LLC now owns 86 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 61 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Amy L. Ladd sold 119 shares of the business’s stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director directly owned 120 shares of the company’s stock, valued at $55,620. The trade was a 49.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 in the last ninety days. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ISRG. JPMorgan Chase & Co. cut their price objective on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. Bank of America cut their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating for the company in a report on Monday, May 18th. HSBC cut their price target on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, TD Cowen cut their price target on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Nineteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $571.28.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $416.55 on Tuesday. The stock has a fifty day moving average of $442.17 and a two-hundred day moving average of $494.54. The company has a market capitalization of $147.53 billion, a PE ratio of 50.49, a price-to-earnings-growth ratio of 3.28 and a beta of 1.46. Intuitive Surgical, Inc. has a fifty-two week low of $396.68 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the previous year, the company earned $1.81 EPS. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.